Lozatap Tablets 100 mg (Losartan Potassium)

Adult dose

This medication can be taken regardless of meals but is recommended to be taken at the same time every day. For hypertensive adults: The initial and maintenance dose is recommended to be 50 mg orally once daily as Losartan Potassium. The maximum antihypertensive effect is observed 3 to 6 weeks after treatment initiation. If the treatment effect is insufficient, the same dose can be divided into two doses daily or increased to a maximum of 100 mg once daily if necessary.

Child dose

Children and adolescents aged 6 years and older (1) Weight 20 kg or more and less than 50 kg: 25 mg orally once daily, can be increased to a maximum of 50 mg once daily depending on blood pressure response. (2) Weight 5

This medication can cause serious harm to the fetus if taken during pregnancy, particularly in the second and third trimesters, and should not be used by women who are pregnant or may become pregnant. If pregnancy is confirmed, the use of this medication should be discontinued immediately, and tests to check the health status of the fetus are necessary. Patients with severely impaired liver function or certain genetic diseases should not take this medication, and elderly patients or those with weak kidney function should use it with caution. Since this medication lowers blood pressure, symptoms of low blood pressure or renal failure may occur; if symptoms arise, medical consultation should be sought immediately. Due to the possibility of hyperkalemia, it is advisable to regularly check potassium levels and not to take potassium supplements or medications containing potassium together with this drug. During treatment with this medication, symptoms such as dizziness or drowsiness may occur, so caution should be exercised when driving or operating machinery. Interactions may occur when taken with other antihypertensive agents, diuretics, or non-steroidal anti-inflammatory drugs (NSAIDs), so it is essential to inform the physician. This medication is not recommended for use in pediatric patients or children under 6 years of age, as safety and efficacy have not been established. In case of overdose, symptoms such as low blood pressure and decreased heart rate may appear, and immediate medical attention should be sought for appropriate treatment. This medication should be stored out of reach of children and should not be transferred to other containers for safety.

Serious side effects

Hives, angioedema (swelling of lips, eyelids, face), difficulty breathing, laryngeal/glottic swelling that may cause vascular occlusion, severe allergic reactions, oligohydramnios, impaired skull formation in newborns, anuria, hypotension, renal failure, worsening kidney function, severe skin reactions (severe rash, blistering, skin peeling, oral/ocular mucosal pain), vasculitis, anaphylactoid syndrome, liver function abnormalities, severe liver impairment, acute.

Mild side effects

Muscle cramps, lower back pain, leg pain, dizziness, nasal congestion, upper respiratory infection, sinusitis, nausea, diarrhea, indigestion, cough, sinus problems, pharyngitis, muscle pain, insomnia, headache, weakness/fatigue, swelling/bloating, abdominal pain, chest pain, swelling of lips/eyelids, facial rash, palm skin peeling, hemolysis, facial edema, fever, orthostatic effects, syncope, angina, second-degree AV block, hypotension, arrhythmia accompanied by myocardial infarction and atrial fibrillation.

This medication should be stored in a tightly closed container to prevent exposure to air and moisture. Additionally, it is recommended to store it at room temperature between 1 to 30 degrees Celsius.

Appearance

White drop-shaped film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle